Nasdaq rises over 100 points; ISM manufacturing PMI slips in September
- Nasdaq Composite rose 0.37% to 26,960.69 on Thursday, driven by a 1.3% gain in energy shares
- Accenture Plc shares surged 18% to $216.07 on strong Q4 results and FY27 guidance
- ISM manufacturing PMI slipped to 54.5 in September, missing consensus estimates of 55
- Corteva Inc shares plunged 84% to $12.15 following the spin-off of its seed business Vylor

*this image is generated using AI for illustrative purposes only.
U.S. stocks traded higher on Thursday, with the Nasdaq Composite gaining around 100 points. The index rose 0.37% to 26,960.69, supported by a 1.3% jump in energy shares. The ISM manufacturing PMI declined to 54.5 in September from 54.6 in August, missing market estimates of 55.
Market performance and sector trends
The broader market showed modest gains alongside the tech-led rally. The Dow Jones Industrial Average edged up 0.06% to 50,936.24, while the S&P 500 rose 0.30% to 7,674.30. In trading on Wednesday, health care stocks fell by 1.2%. Real estate stocks lagged earlier in the week, falling 0.6%.
| Index | Change | Level |
|---|---|---|
| Nasdaq Composite | +0.37% | 26,960.69 |
| S&P 500 | +0.30% | 7,674.30 |
| Dow Jones Industrial Average | +0.06% | 50,936.24 |
Key movers and commodities
Accenture Plc (NYSE: ACN) shares surged 18% to $216.07 after the company reported better-than-expected fourth-quarter financial results and issued FY27 sales guidance above estimates. Nexalin Technology Inc (NASDAQ: NXL) shares shot up 69% to $7.25 after signing a 10-year exclusive distribution deal with Inovanexa Medical Technologies covering seven Latin American markets. Veea Inc (NASDAQ: VEEA) gained 43% to $3.10 following an agreement with TROLLEE Holdings for the phased deployment of VeeaONE solutions across 1,000 unattended stores.
Conversely, Corteva Inc (NYSE: CTVA) shares dipped 84% to $12.15 after completing the spin-off of its advanced seed and genetics business Vylor. Sigma Lithium Corp (NASDAQ: SGML) fell 16% to $7.88 after BMO Capital downgraded the stock from Outperform to Market Perform with a $10 price target. Foghorn Therapeutics Inc (NASDAQ: FHTX) dropped 30% to $2.50 after discontinuing its SMARCA2 degrader collaboration with Lilly.
Commodity markets showed mixed movement. Oil rose 1.7% to $91.91, while gold climbed 0.1% to $4,192.70. Silver gained 0.8% to $61.030, but copper fell 0.8% to $6.5720.
Economic indicators
Recent U.S. economic data presented a mixed picture. The ISM manufacturing PMI declined to 54.5 in September from 54.6 in August, versus market estimates of 55. Construction spending increased by 0.9% month-over-month to an annual rate of $2,203 billion in August versus a revised 0.1% decrease in July. The S&P Global manufacturing PMI declined to 55.9 in September versus a preliminary reading of 57.0. U.S. jobless claims fell by 1,000 to 197,000 in the week ended Sept. 26, down from market estimates of 200,000. U.S. natural-gas stocks rose by 64 billion cubic feet during the week ending Sept. 25.
Global markets
European shares were lower on Thursday. The eurozone’s STOXX 600 declined 1.2%, while Spain’s IBEX 35 Index fell 2%, London’s FTSE 100 fell 1.7%, Germany’s DAX fell 0.9%, and France’s CAC 40 dipped 1.5%. Asian markets closed mixed, with Japan’s Nikkei 225 jumping 3.3%, and India’s BSE Sensex falling 0.79%.
How might the divergence between the declining ISM manufacturing PMI and rising construction spending influence Federal Reserve interest rate expectations for the upcoming quarter?
What are the potential long-term revenue implications for Corteva following the 84% share drop and the spin-off of its Vylor seed and genetics business?
Could the significant 1.3% surge in energy shares, driven by oil prices near $92, lead to sustained outperformance in the energy sector relative to tech-led indices like the Nasdaq?

























